Atossa Therapeutics, Inc. (ATOS)
NASDAQ: ATOS · Real-Time Price · USD
0.8217
-0.0402 (-4.66%)
Jul 25, 2025, 1:26 PM - Market open
Atossa Therapeutics Market Cap
Atossa Therapeutics has a market cap or net worth of $106.14 million as of July 25, 2025. Its market cap has decreased by -26.60% in one year.
Market Cap
106.14M
Enterprise Value
46.22M
1-Year Change
-26.60%
Ranking
Category
Stock Price
$0.82
Market Cap Chart
Since November 8, 2012, Atossa Therapeutics's market cap has increased from $62.00M to $106.14M, an increase of 71.19%. That is a compound annual growth rate of 4.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 24, 2025 | 111.30M | -6.31% |
| Dec 31, 2024 | 118.80M | 7.71% |
| Dec 29, 2023 | 110.30M | 64.87% |
| Dec 30, 2022 | 66.90M | -66.98% |
| Dec 31, 2021 | 202.60M | 197.94% |
| Dec 31, 2020 | 68.00M | 375.52% |
| Dec 31, 2019 | 14.30M | 146.55% |
| Dec 31, 2018 | 5.80M | -17.14% |
| Dec 29, 2017 | 7.00M | 32.08% |
| Dec 30, 2016 | 5.30M | -45.36% |
| Dec 31, 2015 | 9.70M | -72.36% |
| Dec 31, 2014 | 35.10M | -16.03% |
| Dec 31, 2013 | 41.80M | -17.06% |
| Dec 31, 2012 | 50.40M | -18.71% |
| Nov 8, 2012 | 62.00M | - |
View and export this data all the way back to 2012. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 723.06B |
| Johnson & Johnson | 407.97B |
| AbbVie | 337.08B |
| Novo Nordisk | 313.06B |
| UnitedHealth Group | 252.71B |
| AstraZeneca | 228.91B |
| Novartis AG | 227.81B |
| Abbott Laboratories | 218.59B |